Related Experiment Video
Updated: Mar 17, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
Published on: October 20, 2020
Biodegradable polymeric microcapsules for sustained release of riboflavin
A M Abd El-Hay1, A M Naser2, A Badawi3
1Chemistry Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo, Egypt; Solid dosage forms Department, EIPICO, Egypt.
Polylactic acid and polylactic-co-glycolic acid microcapsules were developed for drug delivery. These formulations demonstrated controlled release of riboflavin (RF) with high entrapment efficiency.
Area of Science:
- Polymer chemistry
- Materials science
- Drug delivery systems
Background:
- Polylactic acid (PLA) and polylactic-co-glycolic acid (PLGA) are biodegradable polymers widely used in biomedical applications.
- Developing efficient methods for microencapsulating drugs within these polymers is crucial for controlled release applications.
- The physical and chemical properties of PLA and PLGA influence drug release kinetics and entrapment efficiency.
Purpose of the Study:
- To synthesize polylactic acid and polylactic-co-glycolic acid using a simple, safe, and economical method.
- To microencapsulate riboflavin (RF) within PLA and PLGA matrices using an oil-in-water emulsion solvent evaporation technique.
- To characterize the drug-loaded microcapsules and evaluate their in vitro release performance.
Main Methods:
- Synthesis of polylactic acid and polylactic-co-glycolic acid with yields exceeding 90%.
- Microencapsulation of riboflavin (RF) using the oil-in-water emulsion solvent evaporation method at various drug:polymer ratios.
- Characterization of microcapsules for morphology and entrapment efficiency (E.E.).
- In vitro release studies of RF from the microcapsule formulations over 3 days.
Main Results:
- High yields (>90%) achieved in polymer synthesis.
- Microcapsules exhibited a burst release of RF within the first 12 hours, followed by gradual release over 3 days.
- Cumulative RF release reached 70% for PDLA and 80% for PDLAGA formulations by day 3.
- The highest entrapment efficiency (E.E.) achieved was 85%.
- Release kinetics followed a zero-order pattern.
Conclusions:
- PLA and PLGA can be synthesized efficiently and economically.
- The developed microcapsules effectively encapsulate riboflavin, offering controlled release properties.
- The drug:polymer ratio significantly impacts entrapment efficiency and release profiles.
- These microencapsulation systems show potential for modified drug performance in pharmaceutical applications.
More Related Videos
07:42Author Spotlight: Development and Characterization of Eco-Friendly Lignin-Based Microparticles for Enhanced Delivery of Bioflavonoids
Published on: March 1, 2024
10:07Preparation of Multifunctional Silk-Based Microcapsules Loaded with DNA Plasmids Encoding RNA Aptamers and Riboswitches
Published on: October 8, 2021
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Modified-Release Drug Delivery Systems: Rate-Programmed I
Modified-Release Drug Delivery Systems: Site-Targeted
Modified-Release Drug Delivery Systems: Rate-Programmed II